Tumour Sites: Breast Cancer

Access all ESMO scientific and educational resources on this topic!
Recent medwireNews and resources from conferences are for ESMO Members only.

Tumour Knowledge Portal

Preselected recommended educational resources on this topic

Sofia Braga discusses the results from 3 trials presented at ASCO 2017 that evaluated the role, duration and a combination of adjuvant therapy drugs (dual inhibition) in patients with HER2-positive early breast cancer.

More video interviews on this topic

Factsheets on Biomarkers

05 Aug 2015 HER2 in Breast Cancer Giuseppe Viale
05 Aug 2015 PR in Breast Cancer Giuseppe Viale
05 Aug 2015 ER in Breast Cancer Giuseppe Viale